Evidence map›Paper›PMID 34502030›Full record

ArticleInternational journal of molecular sciences2021

Identifying the Main Functional Pathways Associated with Cognitive Resilience to Alzheimer's Disease.

Marta Pérez-González, Sara Badesso, Elena Lorenzo, Elizabeth Guruceaga, Alberto Pérez-Mediavilla, Ana García-Osta, Mar Cuadrado-Tejedor

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Resistance and Resilience to Alzheimer's Disease.Cold Spring Harbor perspectives in medicine · 2024
    Review
  5. Article
  6. Article
  7. Molecular Mechanisms for Changing Brain Connectivity in Mice and Humans.International journal of molecular sciences · 2023
    Article
  8. Review
  9. Article
  10. Molecular Mechanisms of Alzheimer's Disease III.International journal of molecular sciences · 2022
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Marta Pérez-GonzálezAlzheimer's Disease, Neurosciences Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.ORCID 0000-0002-1693-3361
Sara BadessoAlzheimer's Disease, Neurosciences Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.
Elena LorenzoAlzheimer's Disease, Neurosciences Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.
Elizabeth GuruceagaIdiSNA (Navarra Institute for Health Research), 31008 Pamplona, Spain.ORCID 0000-0003-0547-681X
Alberto Pérez-MediavillaAlzheimer's Disease, Neurosciences Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.ORCID 0000-0003-1926-0972
Ana García-OstaAlzheimer's Disease, Neurosciences Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.
Mar Cuadrado-TejedorAlzheimer's Disease, Neurosciences Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.
Navarre Institute of Health Research · ESInstituto de Salud Carlos III · ES

Funding

"la Caixa" Foundation CI20-00207Ministerio de Ciencia e Innovación PID2019-104921RB-I00
6 · The paper itself

Abstract

Understanding the mechanisms involved in cognitive resilience in Alzheimer's disease (AD) represents a promising strategy to identify novel treatments for dementia in AD. Previous findings from our group revealed that the study of aged-Tg2576 cognitive resilient individuals is a suitable tool for this purpose. In the present study, we performed a transcriptomic analysis using the prefrontal cortex of demented and resilient Tg2576 transgenic AD mice. We have been able to hypothesize that pathways involved in inflammation, amyloid degradation, memory function, and neurotransmission may be playing a role on cognitive resilience in AD. Intriguingly, the results obtained in this study are suggestive of a reduction of the influx of peripheral immune cells into the brain on cognitive resilient subjects. Indeed,

Indexed as

CognitionInflammationAgedAged, 80 and overAlzheimer DiseaseAnimalsCD4 AntigensCerebral CortexFemaleGene Expression ProfilingGene Expression RegulationHumansLeukocytes, MononuclearMaleMiceMice, TransgenicCD4 AntigensAlzheimer’s diseaseCD4+ cellscognitive resilienceinflammation

Identifiers

PMID34502030
PMCPMC8431458
OpenAlexW3195541383

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.